SCM
CGON icon

Soleus Capital Management’s CG Oncology CGON Stock Holding History

Soleus Capital Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.35M Sell
20,000
-150,000
-88% -$8.5M 0.05% 81
2025
Q4 		$7.06M Sell
170,000
-120,000
-41% -$4.97M 0.26% 60
2025
Q3 		$11.7M Buy
290,000
+135,000
+87% +$3.92M 0.59% 40
2025
Q2 		$4.03M Sell
155,000
-148,585
-49% -$3.58M 0.27% 58
2025
Q1 		$7.43M Sell
303,585
-25,000
-8% -$703K 0.54% 44
2024
Q4 		$9.42M Sell
328,585
-12,000
-4% -$411K 0.59% 40
2024
Q3 		$12.9M Sell
340,585
-84,000
-20% -$2.94M 1% 35
2024
Q2 		$13.4M Buy
424,585
+206,714
+95% +$7.16M 1.18% 32
2024
Q1 		$9.56M Buy
+217,871
New +$8.9M 0.71% 42

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM